TKNO Alpha Teknova, Inc.
Healthcare$3.99+2.57%ClosedMarket Cap: $213.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.21
P/S
4.99
EV/EBITDA
-21.95
DCF Value
$-11.61
FCF Yield
-4.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
33.3%
Operating Margin
-39.0%
Net Margin
-41.1%
ROE
-24.3%
ROA
-17.4%
ROIC
-17.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $11.1M | 31.6% | $-4.3M | $-4.6M | $— | — |
| Q4 null | $10.0M | 32.5% | $-4.6M | $-4.8M | $— | — |
| FY null | $40.5M | 33.2% | $-17.0M | $-17.3M | $— | — |
| Q3 null | $10.5M | 30.7% | $-4.0M | $-4.3M | $— | — |
| Q2 null | $10.3M | 38.7% | $-3.4M | $-3.6M | $— | — |
| Q1 null | $9.8M | 30.7% | $-5.0M | $-4.6M | $— | — |
| Q4 null | $9.3M | 23.0% | $-5.6M | $-5.7M | $— | — |
| FY null | $37.7M | 19.2% | $-26.1M | $-26.7M | $— | — |
| Q3 null | $9.6M | 0.9% | $-7.4M | $-7.6M | $— | — |
| Q2 null | $9.6M | 29.2% | $-5.1M | $-5.4M | $— | — |
| Q1 null | $9.3M | 23.8% | $-8.0M | $-8.1M | $— | — |
| Q4 2023 | $7.9M | 17.0% | $-10.9M | $-10.7M | $-0.26 | — |